title: Differentiation of tumor progression and radiation-induced effects after intracranial radiosurgery.
abstract: A number of intracranial tumors demonstrate some degree of enlargement after stereotactic radiosurgery (SRS). It necessitates differentiation of their regrowth and various treatment-induced effects. Introduction of low-dose standards for SRS of benign neoplasms significantly decreased the risk of the radiation-induced necrosis after -management of schwannomas and meningiomas. Although in such cases a transient increase of the mass volume within several months after irradiation is rather common, it usually followed by spontaneous shrinkage. Nevertheless, distinguishing tumor recurrence from radiation injury is often required in cases of malignant parenchymal brain neoplasms, such as metastases and gliomas. The diagnosis is frequently complicated by histopathological heterogeneity of the lesion with coexistent viable tumor and treatment-related changes. Several neuroimaging modalities, namely structural magnetic resonance imaging (MRI), diffusion-weighted imaging, diffusion tensor imaging, perfusion computed tomography (CT) and MRI, single-voxel and multivoxel proton magnetic resonance spectroscopy as well as single photon emission CT and positron emission tomography with various radioisotope tracers, may provide valuable diagnostic information. Each of these methods has advantages and limitations that may influence its usefulness and accuracy. Therefore, use of a multimodal radiological approach seems reasonable. Addition of functional and metabolic neuroimaging to regular structural MRI investigations during follow-up after SRS of parenchymal brain neoplasms may permit detailed evaluation of the treatment effects and early prediction of the response. If tissue sampling of irradiated intracranial lesions is required, it is preferably performed with the use of metabolic guidance. In conclusion, differentiation of tumor progression and radiation-induced effects after intracranial SRS is challenging. It should be based on a complex evaluation of the multiple clinical, radiosurgical, and radiological factors.
authors: Faculty of Advanced Techno-Surgery, Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan. m_chernov@abmes.twmu.ac.jp
authors: Mikhail F
authors: MF
authors: Chernov
authors: Yuko
authors: Y
authors: Ono
authors: Kayoko
authors: K
authors: Abe
authors: Masao
authors: M
authors: Usukura
authors: Motohiro
authors: M
authors: Hayashi
authors: Masahiro
authors: M
authors: Izawa
authors: Sergey V
authors: SV
authors: Diment
authors: Pavel I
authors: PI
authors: Ivanov
authors: Yoshihiro
authors: Y
authors: Muragaki
authors: Hiroshi
authors: H
authors: Iseki
authors: Tomokatsu
authors: T
authors: Hori
authors: Yoshikazu
authors: Y
authors: Okada
authors: Kintomo
authors: K
authors: Takakura
mesh_terms: D001932:Brain Neoplasms / Q000556:secondary* / Q000601:surgery*; D018450:Disease Progression; D006801:Humans; D007091:Image Processing, Computer-Assisted; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D059906:Neuroimaging; D011832:Radiation Injuries / Q000175:diagnosis* / Q000209:etiology; D016634:Radiosurgery / Q000009:adverse effects*; D013997:Time Factors; D015899:Tomography, Emission-Computed, Single-Photon